Medical Journals

7'-substituted Benzothiazolothio- and Pyridinothiazolothio-purines As Potent Heat Shock Protein 90 Inhibitors.

Authors:
  • Zhang Lin
  • Fan Junhua
  • Vu Khang
  • Hong Kevin
  • Le Brazidec Jean-Yves
  • Shi Jiandong
  • Biamonte Marco
  • Busch David J
  • Lough Rachel E
  • Grecko Roy
  • Ran Yingqing
  • Sensintaffar John L
  • Kamal Adeela
  • Lundgren Karen
  • Burrows Francis J
  • Mansfield Robert
  • Timony Gregg A
  • Ulm Edgar H
  • Kasibhatla Srinivas R
  • Boehm Marcus F

From: Department of Medicinal Chemistry, Conforma Therapeutics Corporation, 9393 Towne Centre Drive, Suite 240, San Diego, California 92121, USA. lzhang@conformacorp.com

Journal of medicinal chemistry

  • Publish Date: Aug 2006
  • ISSN: 0022-2623
  • Volume: 49
  • Issue: 17
  • Pages: 5352-62
  • Medium: Print
  • Language: English
  • Citation (JAMA): Zhang Lin, Fan Junhua, Vu Khang, et al. 7'-substituted Benzothiazolothio- and Pyridinothiazolothio-purines As Potent Heat Shock Protein 90 Inhibitors.. J. Med. Chem. Aug 2006;49:5352-62

Abstract

We report on the discovery of benzo- and pyridino- thiazolothiopurines as potent heat shock protein 90 inhibitors. The benzothiazole moiety is exceptionally sensitive to substitutions on the aromatic ring with a 7’-substituent essential for activity. Some of these compounds exhibit low nanomolar inhibition activity in a Her-2 degradation assay (28-150 nM), good aqueous solubility, and oral bioavailability profiles in mice. In vivo efficacy experiments demonstrate that compounds of this class inhibit tumor growth in an N87 human colon cancer xenograft model via oral administration as shown with compound 37 (8-(7-chlorobenzothiazol-2-ylsulfanyl)-9-(2-cyclopropylamino-ethyl)-9H- purin-6-ylamine).

Mesh Headings (Keywords): Animals, Binding Sites, Breast Neoplasms, Cell Line, Tumor, Cell Proliferation, Female, HSP90 Heat-Shock Proteins, Humans, Mice, Mice, Nude, Molecular Structure, Purines, Stereoisomerism, Structure-Activity Relationship, Sulfhydryl Compounds, Time Factors, Xenograft Model Antitumor Assays


Check for Full Text / PubMed Unique Identifier (PMID): 16913725


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.